Asset Dedication LLC’s Sarepta Therapeutics SRPT Stock Holding History

Asset Dedication LLC’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-500	Closed	-$31.9K	–	1224
2025 Q1	$31.9K	Hold	500	–	–	﹤0.01%	553
2024 Q4	$60.8K	Hold	500	–	–	﹤0.01%	449
2024 Q3	$62.4K	Hold	500	–	–	﹤0.01%	479
2024 Q2	$79K	Hold	500	–	–	0.01%	429
2024 Q1	$65K	Hold	500	–	–	﹤0.01%	411
2023 Q4	$48K	Hold	500	–	–	﹤0.01%	435
2023 Q3	$61K	Hold	500	–	–	0.01%	409
2023 Q2	$57K	Hold	500	–	–	﹤0.01%	425
2023 Q1	$69K	Hold	500	–	–	0.01%	397
2022 Q4	$65K	Buy	+500	New	+$57.9K	0.01%	399
2021 Q4	–	Sell	-100	Closed	-$9K	–	1027
2021 Q3	$9K	Hold	100	–	–	﹤0.01%	719
2021 Q2	$8K	Buy	+100	New	+$7.58K	﹤0.01%	670
2020 Q4	–	Sell	-500	Closed	-$70K	–	809
2020 Q3	$70K	Hold	500	–	–	0.02%	311
2020 Q2	$80K	Hold	500	–	–	0.02%	280
2020 Q1	$49K	Hold	500	–	–	0.01%	317
2019 Q4	$65K	Hold	500	–	–	0.02%	272
2019 Q3	$38K	Hold	500	–	–	0.01%	314
2019 Q2	$76K	Hold	500	–	–	0.02%	249
2019 Q1	$60K	Hold	500	–	–	0.02%	262
2018 Q4	$55K	Sell	500 -200	-29%	-$25K	0.02%	255
2018 Q3	$113K	Hold	700	–	–	0.04%	192
2018 Q2	$92K	Buy	+700	New	+$66K	0.03%	214

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Asset Dedication LLC's SRPT Position: Q2 2025 in Review

Asset Dedication LLC sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 500 shares — an estimated $31.9K sold.

Asset Dedication LLC first reported a position in SRPT in Q2 2018 and held it in 22 quarters. The position peaked at $113K in Q3 2018. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

Asset Dedication LLC reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
Asset Dedication LLC sold 500 Sarepta Therapeutics shares in Q2 2025, an estimated $31.9K.
Asset Dedication LLC first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 22 quarters.
Asset Dedication LLC's Sarepta Therapeutics position peaked at $113K in Q3 2018.
362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Asset Dedication LLC's 13F filing for Q2 2025, filed 19 Aug 2025.